Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Bonviva approved in Japan for osteoporosis

July 1, 2013

Subcutaneous Orencia approved in Japan

July 1, 2013

Celgene presents new protein kinase inhibitors

June 27, 2013

Cytokinetics and Astellas form skeletal muscle activator collaboration

June 27, 2013

Roche synthesizes novel BTK inhibitors

June 26, 2013

FDA accepts for review sNDA to expand Xeljanz label

June 25, 2013

Celgene presents results for apremilast in psoriatic arthritis and Behcet's syndrome

June 25, 2013

Phase II results presented for ARA-290 in rheumatoid arthritis

June 20, 2013

Preclinical results and initiation of first-in-human trial of ATROSAB

June 19, 2013

Portola Pharmaceuticals patents novel tyrosine-protein kinase inhibitors

June 18, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...